Title : Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.

Pub. Date : 2004 Sep 15

PMID : 15368322






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer. Anastrozole estrogen receptor 1 Homo sapiens